Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-56,417
Closed -$4.26M 1856
2026
Q1
$4.26M Buy
56,417
+4,772
+9% +$359K 0.03% 396
2025
Q4
$3.85M Buy
51,645
+15,141
+41% +$1.11M 0.03% 395
2025
Q3
$2.46M Sell
36,504
-13,224
-27% -$878K 0.02% 496
2025
Q2
$3.24M Buy
49,728
+14,002
+39% +$839K 0.03% 434
2025
Q1
$2.21M Buy
35,726
+1,699
+5% +$113K 0.02% 501
2024
Q4
$2.45M Buy
34,027
+1,083
+3% +$84.6K 0.02% 476
2024
Q3
$2.68M Buy
32,944
+45
+0.1% +$3.6K 0.03% 452
2024
Q2
$2.44M Sell
32,899
-120
-0.4% -$8.99K 0.03% 452
2024
Q1
$2.57M Sell
33,019
-13,543
-29% -$1.01M 0.03% 457
2023
Q4
$3.33M Sell
46,562
-20
-0% -$1.39K 0.04% 354
2023
Q3
$3.23M Sell
46,582
-522
-1% -$39.4K 0.04% 342
2023
Q2
$3.81M Buy
47,104
+380
+0.8% +$31.1K 0.05% 307
2023
Q1
$3.77M Buy
46,724
+16,318
+54% +$1.31M 0.06% 303
2022
Q4
$2.27M Buy
30,406
+4,435
+17% +$316K 0.04% 414
2022
Q3
$1.68M Buy
25,971
+3,872
+18% +$268K 0.03% 429
2022
Q2
$1.53M Buy
22,099
+5,822
+36% +$432K 0.03% 446
2022
Q1
$1.25M Buy
16,277
+177
+1% +$12.7K 0.02% 521
2021
Q4
$1.23M Buy
16,100
+3,283
+26% +$241K 0.02% 533
2021
Q3
$946K Sell
12,817
-1,368
-10% -$103K 0.02% 585
2021
Q2
$946K Sell
14,185
-52,345
-79% -$3.5M 0.02% 622
2021
Q1
$4.95M Sell
66,530
-7
-0% -$531 0.1% 170
2020
Q4
$4.85M Buy
66,537
+37,348
+128% +$2.64M 0.11% 165
2020
Q3
$1.94M Buy
29,189
+178
+0.6% +$11.3K 0.05% 292
2020
Q2
$1.65M Buy
+29,011
New +$1.42M 0.04% 290

Other funds holding HOLX

Xponance's HOLX Position: Q2 2026 in Review

Xponance sold out of Hologic (HOLX) in Q2 2026, closing a stake of 56,417 shares — an estimated $4.26M sold.

Xponance first reported a position in HOLX in Q2 2020 and held it in 24 quarters. The position peaked at $4.95M in Q1 2021. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Xponance reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Xponance sold 56,417 Hologic shares in Q2 2026, an estimated $4.26M.
  • Xponance first reported a position in Hologic in Q2 2020 and held it in 24 quarters.
  • Xponance's Hologic position peaked at $4.95M in Q1 2021.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.